Shanghai Hongtong

Huitai Medical plans to use 586 million yuan of its own funds to acquire the remaining 37.33% equity in its subsidiary Shanghai Hongtong from minority shareholders, making it a wholly owned subsidiary. The deal is based on a valuation of 1.569 billion yuan for Shanghai Hongtong.